Cygnus Technologies

6 articles with Cygnus Technologies

• Gyros Protein Technologies and Cygnus Technologies Expand Collaboration to Support Improved Bioprocess Impurity Analytics, and Introduce HEK 293 HCP Assay Reagent Set for Gyrolab

  7/7/2021

  Collaboration is poised to deliver a range of ready-to-use bioprocess impurity reagent sets optimized for use with the Gyrolab platform

• Cygnus Technologies Attains ISO 9001:2015 Certification

  9/26/2019

  Cygnus Technologies, a Maravai LifeSciences company, announced that it has achieved ISO 9001:2015 certification.

• Bio-Techne And Cygnus Technologies Announce Partnership For 3G CHO-HCP Assay

  8/13/2019

  Bio-Techne Corporation and Cygnus Technologies, part of Maravai LifeSciences, announced today a strategic partnership for the quantification of Chinese hamster ovary host cell proteins (CHO-HCP) on the ProteinSimple™-branded Ella™ immunoassay platform.

• Cygnus Technologies Introduces Mass Spec Services for Host Cell Protein Impurity Characterization

  6/24/2019

   Cygnus Technologies, a Maravai LifeSciences company, announces an expansion of its service offerings for host cell protein (HCP) analysis.

• New Kit Identifies Endonuclease Impurities in Gene Therapy and Vaccine Development

  4/18/2019

  Cygnus Technologies, the leading assay and services provider for the detection and characterization of impurities in biopharmaceuticals, introduces the EndonucleaseGTP™ ELISA Kit for the detection and quantitation of residual endonuclease impurities in recombinant vaccines and viral vectors used for gene therapy.

• Gyros Protein Technologies and Cygnus Technologies Sign Licensing and Supply Agreement

  7/10/2018

  Gyros Protein Technologies to develop immunoassay kits for biotherapeutic impurity analysis using Cygnus Technologies’ proprietary reagents